EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines Seite 1 – 10.01.2022

The two companies will explore opportunities for a long-term, strategic partnership spanning the CVS Health enterprise
Includes CVS Caremark, the leading pharmacy benefit manager in the U.S., covering 1 in 3 Americans – nearly 110 million lives Initial focus will be on EQRx’s two lead oncology programs with future therapies expected to follow
CAMBRIDGE, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) — EQRx , Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced it has entered into a memorandum of understanding (MOU) with CVS Health. 1 …

Read the source article at Aktien
2022-01-10 04:30:00